There is lack of data regarding outcomes of peritoneal dialysis (PD) in Singapore. The aim of this study is to retrospectively evaluate the patient characteristics, technique survival, and patient survival in a single centre.
INTrODUcTION
Singapore General Hospital (SGH) first started its peritoneal dialysis (PD) programme in 1980 as an alternative to haemodialysis (HD) in view of the rising incidence of end-stage renal disease (ESRD) in the general population. According to the Singapore Renal Registry 2008 1 , there were 4,169 (crude rate of 1,144.5 per million population) prevalent patients on dialysis in Singapore. Of these, 85.7% were on HD and 14.3% were on PD. Diabetic nephropathy was the most common cause of ESRD at 63.5%, followed by chronic glomerulonephritis (GN) at 17.6%. As of 2008, the SGH Peritoneal Dialysis programme handles approximately 60% of patients in the public hospital system.
In line with the projected rise in incidence of ESRD, Singapore Ministry of Health started a series of initiatives to curb the rising healthcare cost associated with ESRD in 2000 2 . In addition to primary and secondary prevention programmes, one of the initiatives included increasing the percentage of patients treated with continuous ambulatory peritoneal dialysis to 40% in 2010, in view of its lower costs via a higher government subsidy programme and lower out-of-pocket payment compared to patients on HD at a voluntary welfare organisation centre. As a result of this financial incentive, the percentage of prevalent PD patients peaked at 20.7% in 2004 as compared to 16 .4% in 2000 1 , and this resulted in a change in the characteristics of the Singapore PD population.
Proceedings of Singapore Healthcare  Volume 21  Number 2  2012 PD was first developed by Popovich et al 3 
and
Oreopoulos et al 4 in the mid-1970s and has since gained popularity worldwide in view of its simplicity and application as an alternative to HD and renal transplantation. It has come to light in the last 30 years that survival differences exist between patients on PD, compared with HD. PD patients have better survival rates in the first and second years of treatment, especially among younger patients without diabetes 5 . In contrast, patients who were older, have diabetes, or more comorbid conditions, survived longer on HD 6, 7 .
There is a lack of publications with regards to patient and technique survival within the PD population in Singapore. This article aims to report clinical characteristics including the relationship between causes of ESRD namely DM and GN on survival outcomes of patients initiated on PD between 2000 and 2008 in the SGH.
METHODOLOGY
Data of all incident PD patients from 1 January 2000 to 31 December 2008 were obtained from hospital electronic medical records and PD charts. Patient data including date of birth, race, gender, primary cause of ESRD, baseline comorbid conditions (ie. DM, cerebrovascular accident (CVA), and ischaemic heart disease (IHD)), and endpoints (ie. death, transfer to HD or renal transplantation, recovery of renal function, lost to follow-up, or until last followup to 31 December 2010) were collected.
In the analysis of technique survival, technique failure was defined as transfer to HD, peritonitisrelated death and withdrawal of PD based on social grounds. Causes of transfer to HD were grouped into infection (peritonitis and catheter infection), dialysis inadequacy (solute or ultra-filtration failure), mechanical or leak issues and others. Patients who were withdrawn from PD due to a successful transplant were not included as cases of technique failure. Peritonitis was defined according to ISPD guidelines with two of the following; abdominal pain and cloudy dialysate, effluent cell count with white blood cells of more than 100/mL and/or a positive effluent microbiological culture. Events for patient survival included death from cardiac, infection, CVA, cancer-related, conservative grounds, others and unknown causes.
Statistical analyses were performed with SPSS Inc. (version 17.0.1 for Windows; Chicago, IL, USA) with data shown in means with standard 
Patient and Technique Survival
The 1, 2, 5 and 10-year patient survival rates were 88.7%, 77.7%, 39.8% and 15.4%, respectively (Fig.  3) . The predominant causes of death were cardiac (37.8%), non-PD related infections (29.3%) and PD peritonitis (13.8%). In this study population, patient survival rates were significantly better in patients with ESRD secondary to GN, as compared with DM ( Fig. 4 ). When stratified by age, patients aged 65 years and older (19.8%) had lower five-year survival rates, compared with those aged less than 65 years (49.7%) (P <0.001).
Patients who have ESRD due to DM were more likely to die from a cardiac cause, compared with patients with ESRD due to other causes (41.1% versus 29.7%, P=0.009). Table 2 shows the causes of death for the whole study population, as well as causes of death in patients with ESRD due to DM or GN.
The 1, 2, 5 and 10-year technique survival rates were 92.9%, 85.0%, 64.8% and 32.9%, respectively (Fig. 5 ). The causes of technique failure were peritonitis (63.5%), mechanical malfunction or leaks (11.5%), social grounds (10.8%), dialysis inadequacy (6.4%), catheter infections (4.4%) and others (3.4%). There were 43% patient deaths in the peritonitis sub-group. There were no significant differences in rates of peritonitis-related technique failure in persons with ESRD secondary to DM or GN. Overall technique survival was significantly better in patients with ESRD due to GN, compared with ESRD due to DM (Fig. 6) .
DIScUSSION
This is a single-centre study and the outcomes demonstrated here are unique to this study population. Comparisons of overall patient survival with other studies are shown in Table 3 . When compared with patient groups from other Asian studies 8, 9 , our patients were older, and a larger proportion had ESRD due to DM. Older age and DM are well-established adverse prognostic factors 14 , which may partially explain the lower patient survival rates observed in our study. Another factor which influenced patient survival was the inclusion of patients previously on haemodialysis or renal transplantation. A study by Heaf et al 15 showed poorer survival of PD patients previously on haemodialysis as compared to those primarily initiated on PD. This may be due to a loss of residual renal function which is a major determinant of survival in PD patients [16] [17] [18] .
Compared with survival outcomes for HD from 1999 to 2008 from the Singapore Renal Registry, our study showed a poorer five-year survival rate for PD (39.8% versus 58.9%). One possible explanation for the poorer survival observed in PD patients compared with HD patients is negative selection bias. The number of patients with more comorbid conditions had increased from 2000 through to 2008 partially contributed by the change in healthcare subsidies with increased support for PD by the government since 2000 2 . Patients with multiple comorbid conditions such as IHD and CVA with poor performance status (ie. assisted activities of daily living or unable to ambulate) which would otherwise have precluded them from HD were able to initiate dialysis via PD. These patients can undergo assisted dialysis by a domestic helper or family member. These poor prognostic factors, combined with the high cardiac and infection rates observed in our study population, affected patient survival rates. When patient survival was analysed by ESRD cause, superior rates were seen in patients with ESRD due to GN, as compared to those due to DM. A recent report by the Canadian registry showed similar unadjusted five-year survival rates in PD patients with ESRD secondary to GN (72.1%) and those due to DM (40.6%) 19 . In this registry data, the majority of PD patients were aged between 45 and 64 years (39.2%). It is of interest to note that prevalence of ESRD due to DM in the PD population was only 30.5% as compared to 58% in our study population. Prevalence of ESRD due to GN was, however, similar to our study population (18.2% versus 23.3%).
There are difficulties when comparing technique survival with other study populations in view of differences in the definition of technique survival ( 23 and lipids 24 which may reduce atherosclerotic events. While Singapore does not follow a "PD First" rule 25 , PD is increasingly regarded as the preferred dialysis modality in the older and less mobile age group. The limitations in this retrospective study include lack of information on peritoneal membrane transport characteristics 26 , residual renal function 27, 28 and nutrition 29 information which are risk factors for survival in PD patients.
cONcLUSION
There are distinct differences between patient and technique survival rates at our centre. Our technique survival rates are not inferior to other Asian centres. The poorer patient survival at our centre may reflect the older age and higher comorbid load of our patients.
In Western societies, PD is a modality offered to the independent patient, while HD is a modality for patients who need help with dialysis (ie. physically dependent). PD recruitment and subsequent outcome of programme, therefore, is dependent on government policy, social structure (ie. availability of domestic helper), and patient awareness of modality benefits. PD is a viable, cost-effective alternative of renal replacement therapy. Public awareness of the benefit of this therapy, in particular survival benefit in the early stages of ESRD, needs to be heightened. The overall survival of the cohort however, is strongly affected by morbidity.
With the onset of ESRD, patients should have a "life plan post-ESRD". This should include transplantation as the first choice followed by either PD first if there is no medical contraindication, then HD once the benefit of PD is overcome 30 . It is inevitable that patient outcome will be a continual long-term challenge to any PD programme with the increasing age and comorbidity of patients. Despite this, the enhancement in PD technology has improved survival outcomes. As shown in the recent paper by Mehrotra et al, based on the USA Renal Data System, PD survival is comparable to HD 31 .
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